Stay updated on Augmenting TRD with Allopregnanolone Analog Clinical Trial

Sign up to get notified when there's something new on the Augmenting TRD with Allopregnanolone Analog Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Augmenting TRD with Allopregnanolone Analog Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T21:21:05.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the results of a study related to the treatment of Treatment-Resistant Depression with Ganaxolone, a neuroactive steroid analog.
    Difference
    0.2%
    Check dated 2024-06-06T14:28:07.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage now includes a section titled 'Period Title: Overall Study' which provides detailed baseline characteristics of participants, including age, sex, and race. Additionally, the section specifies the mean age of participants and the count of female and male participants.
    Difference
    33%
    Check dated 2024-05-22T21:38:39.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:53:01.000Z thumbnail image

Stay in the know with updates to Augmenting TRD with Allopregnanolone Analog Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Augmenting TRD with Allopregnanolone Analog Clinical Trial page.